Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorena Rami

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Plos One|May 26, 2022
Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease riskMuhammad Ali, Yun Ju Sung, Fengxian Wang, et al.
Frontiers in Aging Neuroscience|July 11, 2018
Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative DataIsabelle Bos, Stephanie J B Vos, Willemijn J Jansen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 22, 2025
SCD-plus features and AD biomarkers in cognitively unimpaired samples: A meta-analytic approach for nine cohort studiesElizabeth Kuhn, Hannah M Klinger, Rebecca E Amariglio, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 12, 2025
Amyloid-negative neuropsychological norms: Added value in the era of biomarkers and disease-modifying therapiesSara Rubio-Guerra, Isabel Sala, María Belén Sánchez-Saudinós, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 12, 2025
Development of amyloid-negative neuropsychological norms using GAMLSSSara Rubio-Guerra, María Belén Sánchez-Saudinós, Isabel Sala, et al.
Science Translational Medicine|August 16, 2019
The <i>MS4A</i> gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease riskYuetiva Deming, Fabia Filipello, Francesca Cignarella, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2025
Decreased practice effects in cognitively unimpaired amyloid betapositive individuals: a multicenter, longitudinal, cohort studyAdrià Tort-Merino, Agnès Pérez-Millan, Neus Falgàs, et al.
Brain : a Journal of Neurology|July 30, 2015
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjectsJon B Toledo, Henrik Zetterberg, Argonde C van Harten, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 7, 2014
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's diseaseFrank Jessen, Rebecca E Amariglio, Martin van Boxtel, et al.
Translational Psychiatry|November 23, 2020
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery datasetShengjun Hong, Dmitry Prokopenko, Valerija Dobricic, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Plos One|May 26, 2022
Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease riskMuhammad Ali, Yun Ju Sung, Fengxian Wang, et al.
Frontiers in Aging Neuroscience|July 11, 2018
Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative DataIsabelle Bos, Stephanie J B Vos, Willemijn J Jansen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 22, 2025
SCD-plus features and AD biomarkers in cognitively unimpaired samples: A meta-analytic approach for nine cohort studiesElizabeth Kuhn, Hannah M Klinger, Rebecca E Amariglio, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 12, 2025
Amyloid-negative neuropsychological norms: Added value in the era of biomarkers and disease-modifying therapiesSara Rubio-Guerra, Isabel Sala, María Belén Sánchez-Saudinós, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 12, 2025
Development of amyloid-negative neuropsychological norms using GAMLSSSara Rubio-Guerra, María Belén Sánchez-Saudinós, Isabel Sala, et al.
Science Translational Medicine|August 16, 2019
The <i>MS4A</i> gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease riskYuetiva Deming, Fabia Filipello, Francesca Cignarella, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2025
Decreased practice effects in cognitively unimpaired amyloid betapositive individuals: a multicenter, longitudinal, cohort studyAdrià Tort-Merino, Agnès Pérez-Millan, Neus Falgàs, et al.
Brain : a Journal of Neurology|July 30, 2015
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjectsJon B Toledo, Henrik Zetterberg, Argonde C van Harten, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 7, 2014
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's diseaseFrank Jessen, Rebecca E Amariglio, Martin van Boxtel, et al.
Translational Psychiatry|November 23, 2020
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery datasetShengjun Hong, Dmitry Prokopenko, Valerija Dobricic, et al.
Pageof 12